Related Experiment Videos
Seven days of ceftriaxone therapy is as effective as ten days' treatment for bacterial meningitis
Insights
A shorter, seven-day ceftriaxone course for bacterial meningitis is as effective as ten days, with similar complication rates. Patients on the shorter regimen experienced earlier hospital discharge.
Area of Science:
- Pediatric Infectious Diseases
- Clinical Pharmacology
- Bacteriology
Background:
- Bacterial meningitis remains a significant cause of childhood morbidity and mortality.
- Optimal antibiotic duration for bacterial meningitis is crucial for effective treatment and minimizing complications.
- Ceftriaxone is a commonly used antibiotic for bacterial meningitis.
Purpose of the Study:
- To compare the efficacy and safety of a seven-day ceftriaxone therapy versus a ten-day regimen for pediatric bacterial meningitis.
- To evaluate neurological complications, nosocomial infections, and fever patterns in both treatment groups.
Main Methods:
- Seventy-nine children with bacterial meningitis were randomized to receive either seven or ten days of ceftriaxone.
- Causative agents included Haemophilus influenzae, Streptococcus pneumoniae, Group B Streptococcus, and Neisseria meningitidis.
- Clinical outcomes, neurological examinations, cerebrospinal fluid cultures, and complication rates were assessed.
Main Results:
- No significant differences in neurological complications or cerebrospinal fluid culture findings were observed between the seven-day and ten-day ceftriaxone groups.
- Rates of nosocomial infections and fever were similar in both groups.
- Diarrhea was reported in 44% of patients; however, the seven-day regimen led to earlier hospital discharge by approximately two days.
Conclusions:
- A seven-day course of ceftriaxone is a safe and effective alternative to a ten-day regimen for treating bacterial meningitis in children.
- Shorter treatment duration can lead to reduced hospital stay without compromising patient outcomes.
- Further research may support optimizing antibiotic duration for pediatric meningitis.
Abstract:
Seventy-nine children were enrolled in a study to compare seven vs ten days of ceftriaxone therapy for bacterial meningitis. On the basis of a computer-generated list of therapy assignments, 35 children with Haemophilus, pneumococcal, or group B streptococcal meningitis each were assigned to seven- or ten-day treatment regimens; nine children with meningococcal meningitis received seven days of therapy. The population characteristics and etiologic agents were similar for the two treatment groups, as were also the findings on examination and culture of cerebrospinal fluid at completion of therapy. There were no significant differences in the frequency and types of neurological complications between the two treatment groups; four patients in each group had two or more neurological abnormalities. The rates of nosocomial infections and prolonged and secondary fever were similar in those who received seven days of therapy compared with patients treated for the conventional ten days. Diarrhea occurred in 44% of those receiving the drug. Patients treated with the seven-day regimen were discharged from the hospital approximately two days earlier than those with the ten-day regimen.